{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:38:58Z","timestamp":1649097538353},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jac\/dkx408","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T11:09:22Z","timestamp":1507720162000},"page":"828-829","source":"Crossref","is-referenced-by-count":1,"title":["Comment on: High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?"],"prefix":"10.1093","volume":"73","author":[{"given":"Benjamin","family":"Davido","sequence":"first","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelien","family":"Dinh","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Matt","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"},{"name":"Universit\u00e9 Versailles-Saint-Quentin F78180, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Senard","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"},{"name":"Universit\u00e9 Versailles-Saint-Quentin F78180, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurene","family":"Deconinck","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"},{"name":"Universit\u00e9 Versailles-Saint-Quentin F78180, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederique","family":"Bouchand","sequence":"additional","affiliation":[{"name":"Pharmacie, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Salomon","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses, H\u00f4pital Universitaire Raymond-Poincar\u00e9, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, 92380 Garches, France"},{"name":"Universit\u00e9 Versailles-Saint-Quentin F78180, France"},{"name":"UMR 1181, Inserm, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"key\n\t\t\t\t20180216030007_dkx408-B1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkx333","article-title":"High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003\u201315): time to consider point-of-care or molecular testing for precision treatment?","volume":"73","author":"Thakur","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B2","doi-asserted-by":"crossref","first-page":"e87849","DOI":"10.1371\/journal.pone.0087849","article-title":"Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B3","first-page":"1466","article-title":"Repurposing an old drug: aztreonam as a new treatment strategy for gonorrhoea","volume":"72","author":"Davido","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B5","first-page":"13","article-title":"Single dose aztreonam in treating gonorrhoea","volume":"63","author":"Tait","year":"1987","journal-title":"Genitourin Med"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B6","volume-title":"WHO Guidelines for the Treatment of Neisseria gonorrhoeae","author":"WHO","year":"2016"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B7","doi-asserted-by":"crossref","first-page":"612.","DOI":"10.1093\/infdis\/148.3.612","article-title":"Effectiveness of aztreonam, a new monobactam antibiotic, against penicillin-resistant gonococci","volume":"148","author":"Miller","year":"1983","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B8","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/AAC.36.8.1682","article-title":"Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand","volume":"36","author":"Clendennen","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3201\/eid2201.150868","article-title":"New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan","volume":"22","author":"Deguchi","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMc1408109","article-title":"A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia","volume":"371","author":"Lahra","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180216030007_dkx408-B11","author":"EUCAST"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/3\/828\/23823551\/dkx408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T08:00:10Z","timestamp":1518768010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/3\/828\/4604700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,11,8]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx408","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,11,8]]}}}